Search Results 1361-1370 of 16312 for Chronic Lymphocytic Leukemia

  1. A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients With AML - Mayo Clinic

    Diagnosis of either acute promyelocytic leukemia or blast chronic myelomonocytic leukemia; Known history of BCR-ABL alteration; Advanced malignant hepatic ...

  2. Resources for medical professionals - Mayo Clinic

    We are uncovering the cause and course of cancer for each person and translating our findings into better prevention, screening, diagnosis, treatment and ...

  3. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    Phase 4 trials look at long-term safety and effectiveness, after a new ... Stable or persistent disease;; Complete remission and relapse < 6 months ...

  4. A Study of to Determine the Effectiveness and Safety of Ligelizumab in the Treatment of Chronic Spontaneous Urticaria (CSU)(Hives) in Adolescents and Adults Inadequately Controlled With H1-antihistamines. - Mayo Clinic

    The purpose of this study is to establish effectivess and safety of ligelizumab in adolescent and adult subjects with Chronic Spontaneous Urticaria (CSU), or ...

  5. Cancer rehabilitation - Mayo Clinic

    Help you cope with anxiety, distress or other emotional issues; Reduce fatigue, pain and other lingering side effects; Return to work; Formulate a long-term ...

  6. Overview - Department of Cancer Biology - Mayo Clinic Research

    ... diagnosis, prevention and treatment. New discoveries bring hope. See Transcript for_video New discoveries bring hope. The mission of the Department of Cancer ...

  7. A Bio-bank for Patients with Inflammatory Bowel Disease Associated Neoplasia - Mayo Clinic

    ... long-term goal of improving effectiveness of neoplasia detection in patients using non-invasive biomarkers to assist colonoscopy and radiographic screening.

  8. Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma - Mayo Clinic

    Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB. Rochester ...

  9. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease - Mayo Clinic

    The primary objective of this study is to evaluatge whether ustekinumab induces a similar proportion of pediatric participants with moderate-to-severe, active ...

  10. Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully completed ...